Peritonitis due to Pseudomonas putida in a Patient Receiving Automated Peritoneal Dialysis

• Published in: Infection Vol. 36; no. 4; pp. 379 - 380
• Main Authors: Dervisoglu, E, Dundar, D. O, Yegenaga, I, Willke, A
• Format: Journal Article
• Language: English
• Published: Munchen Munchen : Urban and Vogel 01.08.2008; Urban and Vogel; Springer; Springer Nature B.V
• Subjects: Adult; Anti-Bacterial Agents - pharmacology; Anti-Bacterial Agents - therapeutic use; Automation; Biological and medical sciences; Case Report; Ceftazidime - pharmacology; Ceftazidime - therapeutic use; Family Medicine; Female; General Practice; Humans; Infectious Diseases; Internal Medicine; Kidney Failure, Chronic - therapy; Medical sciences; Medicine; Medicine & Public Health; Miscellaneous; Peritoneal Dialysis; Peritonitis - drug therapy; Peritonitis - microbiology; Pseudomonas Infections - drug therapy; Pseudomonas Infections - microbiology; Pseudomonas putida; Pseudomonas putida - drug effects; Pseudomonas putida - isolation & purification; Public health. Hygiene; Public health. Hygiene-occupational medicine; Treatment Outcome; Pseudomonas Putida; Cefazolin; Peritoneal Dialysis; Peritonitis; Ceftazidime; Pseudomonadales; Nosocomial infection; Antibiotic; Bacteria; Pseudomonadaceae; Hospital; Pseudomonas; Hygiene; Urology; Peritoneum
• ISSN: 0300-8126; 1439-0973; 1439-0972
• DOI: 10.1007/s15010-007-6349-8

A patient, who had recently undergone a laparoscopic ovarian cyst operation, receiving nightly automated peritoneal dialysis treatment, was discovered to have peritonitis due to Pseudomonas putida. She was successfully treated with a 21-day course of intraperitoneal ceftazidime and gentamicin, without needing to remove the dialysis catheter. No recurrence was observed over 3 months of follow-up.